APK Oasis

Advisors Asset Management Inc. Purchases 6,839 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

From Market Beat

Advisors Asset Management Inc. Purchases 6,839 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Advisors Asset Management Inc. grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 24.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,639 shares of the medical device company's stock after purchasing an additional 6,839 shares during the period. Advisors Asset Management Inc.'s holdings in Cooper Companies were worth $3,822,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Quent Capital LLC boosted its stake in shares of Cooper Companies by 300.0% in the 1st quarter. Quent Capital LLC now owns 828 shares of the medical device company's stock valued at $84,000 after purchasing an additional 621 shares in the last quarter. Acadian Asset Management LLC grew its stake in shares of Cooper Companies by 300.0% during the first quarter. Acadian Asset Management LLC now owns 720 shares of the medical device company's stock valued at $73,000 after buying an additional 540 shares during the last quarter. Covestor Ltd grew its stake in shares of Cooper Companies by 305.9% during the first quarter. Covestor Ltd now owns 276 shares of the medical device company's stock valued at $28,000 after buying an additional 208 shares during the last quarter. O Shaughnessy Asset Management LLC increased its holdings in shares of Cooper Companies by 443.6% in the first quarter. O Shaughnessy Asset Management LLC now owns 4,876 shares of the medical device company's stock worth $495,000 after buying an additional 3,979 shares during the period. Finally, American International Group Inc. lifted its stake in shares of Cooper Companies by 298.7% in the 1st quarter. American International Group Inc. now owns 52,749 shares of the medical device company's stock valued at $5,352,000 after acquiring an additional 39,520 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

In other news, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares of the company's stock, valued at approximately $520,488.54. This represents a 24.94 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the transaction, the chief operating officer now directly owns 44,696 shares of the company's stock, valued at approximately $4,714,534.08. This represents a 72.01 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 256,373 shares of company stock worth $27,637,427. 2.00% of the stock is currently owned by company insiders.

A number of equities analysts have commented on COO shares. Piper Sandler lifted their price target on Cooper Companies from $115.00 to $120.00 and gave the stock an "overweight" rating in a research note on Thursday, August 29th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a report on Thursday, August 29th. Stifel Nicolaus reissued a "buy" rating and set a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Wells Fargo & Company boosted their price objective on shares of Cooper Companies from $110.00 to $115.00 and gave the company an "overweight" rating in a research report on Thursday, August 29th. Finally, Robert W. Baird increased their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an "outperform" rating in a report on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $117.00.

Get Our Latest Report on COO

COO opened at $100.80 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a 52 week low of $82.21 and a 52 week high of $112.38. The stock has a market cap of $20.08 billion, a PE ratio of 56.16, a PEG ratio of 2.14 and a beta of 0.99. The business has a 50 day moving average of $105.91 and a 200-day moving average of $98.26.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company's revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.84 earnings per share. Equities research analysts predict that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

Previous articleNext article

POPULAR CATEGORY